Acadia Healthcare (NASDAQ:ACHC) Releases FY 2024 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided EPS guidance of 3.350-3.450 for the period, compared to the consensus EPS estimate of 3.520. The company issued revenue guidance of $3.2 billion-$3.2 billion, compared to the consensus revenue estimate of $3.2 billion. Acadia Healthcare also updated its FY24 guidance to $3.35-$3.45 EPS.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $52.08 on Thursday. Acadia Healthcare has a one year low of $50.20 and a one year high of $87.77. The stock has a market capitalization of $4.83 billion, a price-to-earnings ratio of -372.00, a PEG ratio of 1.57 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18. The company has a 50-day simple moving average of $67.15 and a 200-day simple moving average of $68.18.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The company had revenue of $796.00 million for the quarter, compared to analyst estimates of $784.38 million. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The firm’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.92 EPS. On average, analysts predict that Acadia Healthcare will post 3.51 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Royal Bank of Canada reaffirmed an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a report on Friday, September 20th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research note on Tuesday, October 1st. KeyCorp started coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Deutsche Bank Aktiengesellschaft increased their target price on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, Barclays lowered their price target on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a report on Monday, September 30th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $86.67.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.